Member Info for marve

For anyone interested to see our week by week progress on WHO, see the link below, which I have put together

I have also compared us against a company who were given WHO emergency use in early September

https://pdfhost.io/v/kE9W2Kr6x_WHO_progress_comparisonpdf.pdf

https://extranet.who.int/pqweb/sites/default/files/documents/SARS-CoV-2_status_ongoing_applications_20201117.pdf

Dossier review now showing as info requested (different to last week), which matches back to rns today stating recent contact from WHO, hopefully should be final step in getting WHO

For anyone who has gone back over the weekly reports since March, will know that companies are on the progress list for months and months before getting approval, many do not even get this far (that is shown by how many are on the exclusive emergency use list)

If the FDA/EUA is anything like this, as we have been told there are thousands of applications, then it just takes time, even though none of us want to have to wait

The important thing for me tomorrow is more detail, if we can get it, on how the Beckman link will work, it is my opinion that Beckman via Cytiva was always our plan from the start, but we are yet to be told the full picture of this, for example is the european potential contract linked to Beckman

I only hope that we are not caught by Beckman restrictions on them not wanting to release information on their plan until FDA/EUA is given, after all it is Genedrive's test, but Beckman's roll out of machines and infrastructure, so sadly I do fear we are at the mercy of what Beckman want to say (remember the 2 weeks for lawyers agreeing a simple rns for us 2 months ago)

apologies meant latter, i am long term holder here and always will be until i see true value realised

all the best to us over next few months

thought i would stick a post in here for first time in a while, after the short term nature of the money in the covid sector means volatile movements for covid stocks, thus creating arguments and conflicts between all involved, be it short term trader or long term holder (of which i am the former), anyway this is my only post for now, and is based on the perception of the ce marking from may

a CE marking does not show that the test works, or carries any health regulatory approval for covid 19, the CE marking shows the manufacturer has checked the product meets EU requirements

for various reasons, the WHO and FDA/EUA approvals are taking far longer than they did back in March and April, you only have to look at the WHO reports each week to see how long companies are on there for, they do not get turned around in a matter of weeks

once the QMS (quality management standard) stage is complete (which requires ISO 13485 compliance, which GDR updated in July), the pattern for other companies shows it then takes at least another 4 weeks for dossier review to be complete (GDR is now 4 weeks on from QMS being complete), and based on the prequalification process, lab evaulation is the final step which will sign off dossier review - conclusion? WHO approval is now imminent baring any product issues which would cause delay - also Genedrive has in fact moved through the WHO approval process faster than most, including the likes of Thermo Fisher, so keep that in mind

anybody can check the WHO list of approved tests, it is very small, then compare it to how many tests appear on the application list (there is an incredible amount), just shows how hard it is to get on WHO approved list and the very big percentage who fail the process and never make it

also, for every FDA/EUA submission, the manufacturer is allocated a lead reviewer who can be contacted, so i doubt David Budd is sat waiting and has no idea on what stage we are at with it

if GDR fails as a company selling covid tests, it will be because we do not get WHO approval and FDA/EUA, not because we we cant sell a CE marked product

only takes looking at NCYT history to see how things really got going on a commercial basis after WHO and FDA/EUA was given, their sales in February and March on basis of CE marking included for research purposes (because back then everybody needed to carry out research on what covid testing was), sales for research purposes is not a long term commercial basis

Teabiscuit, i read it that we produced the bead, then at some point we decided that we can take it one step more, and improve how the the results are interpreted from the machine, so we then developed the software to do this, this software was not mentioned back in May at all as far as i am aware

so my belief is we waited until we had the software complete, before we submitted the other approvals (different approach to how we went for the initial CE on the bead)

maybe there was some initial feedback from analysis of the bead that led us to go ahead and develop this software that we think would make our whole product even better

the only question i could ask is why we were not told earlier that we were doing this extra software to enhance the product

its just my view, but the above fits, so i think it could be a very important part of the puzzle, again if we had been told about this it would have been more understandable why things have been delayed a bit longer than we hoped

The exporter software was mentioned in the webinar presentation mid June, this was the first time we heard of it, the CE marking for this was only announced today (we did not know it needed separate CE marking)

We know the bead manufacturing was completed early May and the CE marking for that was mid May, where the product was then sent to potential customers for analysis

Genedrive cleary want to sell the complete product, test and software together, as opposed to letting the lab equipment analyse the sample in the way it previously had for other tests

You either believe the latest CE marking of the software now gives them what they want when trying to sell the test, or you believe that the test is too late to market and product evolution like ours will not penetrate the market

None of us knew the software needed separately CE marking, maybe that is why they held back on the other approval submissions that went in June to the different nations, so they could submit the bead and software together (not separately)

Thats my comment for now, holding as I believe big sales will come, cant top up as im skint already

Saint

You need premium membership

to all the other non premium members on here, and those that simply dont have a login but just read the board, then im sorry, but i dont see why i should continue to post on here while the board has become over run by a small minority of individuals

it quite frankly is a waste of my time, i hold shares here for the upcoming approvals and orders that i believe will massively change this company's future, nothing more to be said than that for now

safy, you are quite simply an inexperienced investor who is out of your depth

you never answered why you were posting in april on Tils when you were 50% down, you were saying the exact same things as you are now on Gdr

you do not understand the word ramper, go check out the pile of dog turds on aim that are being ramped to find the true rampers and shysters

those investors here, the ones who hold big amounts, not £500 punts, do not feel the need to constantly drone on and on and on every day, its pointless and not productive, its an efficient use of their time

there, ive actually had a go at someone which i said i never condoned doing on these boards, how about just report me so i cant post anymore, but its ok, i can still private message other premium members on here

Safy, I see you bought into Tils at roughly 90p which I assume must have been in March, and by end of April you were down 50% and saying in essence the company had nothing to offer and people might as well sell, but you were not going to sell, did you hold and get your money back or even still hold to this day and you are in profit now Tils are over £1?

Secondly, I see on 4th May you posted this on Gdr board:

"no knobs on the GDR chat. So far it’s all been civil and informative"

But on 6th May you posted:

"pump and dump"

"even the directors of GDR are at it"

"today I learnt something the hard way. I lost around £4K because of it"

I appreciate if you also have had bad experiences on Hemo and Pyc you might be in the mode of hoping for the best but expecting the worst now

drlong, she is late getting home as she has been round to mine and benches for some rampy fun...

sam, i am sure part you is thinking about those gains that you could have made on the stocks you sold to buy in here, im sure you know thats not best way to look at things

the rest, i am sure everyone here would have expected some form of approval, distribution and sales update by now, the issue is that we can discuss the potential problems why, but is it productive, is it efficient, i certainly aint wasting my time have a discussion that i will never act on, nobody on here is changing my mind, that would definitely fit the "dont believe what you read on a bulletin board" saying

you all have the right to think what you want, and i am sure the long wait will have put some off, well we know it has, but the share price action is not just applicable to gdr, every other covid stock has lost some sentiment over the last month to 6 weeks

my view, if this was an exploration company with a drill that should have hit total depth and logged data comfortably before end of june then i would be worried, but gdr is not such company

the excellent flyingmachine has already posted that our test has been looked over by indian authorities but there is a hold up in finalising what needs to be done, and if some readers on here want to take that as a complete unconfirmed made up ramp, then it is a complete contradiction to believing made up reasons of why the delay is a bad thing

discuss the bad points all you like, but it aint going to change my decision on gdr, so i dont find it an efficient and productive use of mine time to be involved, in fact why have i even just taken the time to type this response, i must be mad to be on here as much as i am

i dont expect you to agree, but gdr does not have a ramp crew, you need to go and read plenty other boards on lse to see what ramp crews are really like

"As a community we need to work together. We have a common interest. We want to see GDR do well. That means kicking up the dirt, digging deep, trying to find out what’s really going on, objectivity, confronting difficult scenarios. Not spin and lie pretending everything in front of us is just perfect."

i might be wrong, so be it, i can accept it when i am wrong, but you come across as someone who is very new to investing, and not only does your profile show this with the date you joined lse, 8 april 2020

all the best to you

Seems we have a few sophomaniacs on here with fragile egos

I wonder, as it seems there are people on here that would prefer to lose money, so long as they predicted the potential adverse result so can come on and say told you so

The sooner some can take their investment back with zero loss and move on the better, I don't think this type of investment is best suited to them

I have seen this mentioned elsewhere, the CEO of Abingdon Health (who are part of the UK rapid test consortium with ODX) is Chris Yates

Chris Yates is a non executive director of Genedrive

So in theory we have a big enough link to the UK government in that sense, whether it translates to anything mind we will have to see

apologies Technik if my post came across as a bit muddled what i was asking

effectively we have created two new ways of working:

1. mixing the sample with the necessary ingrediants

2. analysing the mix and determinig the result

as long as some labs dont turn round and say, love number 1 but we are unable to do number 2 because of x, y or z reason

thats the kind of technical question i was wondering, whether like a proper basic lab is not high tech enough etc

thanks tech

safy, i was looking at it more from point of view, our bead might be amazing, but is there any chance that we have forced this exporter software as part of the process, hence i wondered how the current actual process worked

like if current labs have the 96 plate, but they dont use a computer or whatever to analyse results, is this something that part of the genedrive test they would need

again this is absolutely not my field, and only somebody like technik would know the workings of a lab

if the old way has always been to manually determine the result from tests then so be it, just means our computer/software is an advancement in the process too

so the fact the bead is a whole new creation (that we have been told), which means a whole new way or working compared to the old mixing, the software will likely be a whole new thing too maybe

something new and better just takes time to get going, old methods are never easy to move away from thats all

based on your diagnostic knowledge, could i just ask what your thoughts are on the software tool that we created "the genedrive exporter"

as per the presentation we created the software to go along with the test on open platform, "the genedrive exporter" takes the data off the third party instrument, does the interpretation and displays a colour coded graphic of the results

this is one of the listed benefits of our test, as nobody else had such "human rna controls"

my questions are:

-is such a software type tool to go along with the test commonplace?

-what way will the other pcr test results be identified, like manual looking at what colour the mix and sample has turned?

so 3 months for £4 then, hardly the worst thing ever LP

we might be able to see the short term rainbows from our greenhouse, but wont be long before our beanstalk has grown into a giant that touches the skys

its not long ago sam that you were the most enthusiastic poster on here, you even had reputation of annoying a few

i refrain from using the word ramper, because if the product sells big then the share price could ultimatley reach your once lofty targets

let me know mate will try to look out for your reply